$9.280
+0.973 (+10.48%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Benitec Biopharma Inc (BNTC) Moving Averages Convergence Divergence (MACD) indicator is -0.33, suggesting BNTC is Sell.
Benitec Biopharma Inc (BNTC) 20-Day simple moving average is 8.67, while Benitec Biopharma Inc (BNTC) share price is $—, making it Buy.
Benitec Biopharma Inc (BNTC) 60-Day simple moving average is 10.59, while Benitec Biopharma Inc (BNTC) share price is $—, making it Sell.
Technical Analysis for BNTC
AI Technical BNTCAs of 2026-11-03, the technical board for Benitec Biopharma Inc (BNTC) reads sell: 4 indicators are flashing buy, 6 are indicating sell, and 3 are neutral. Price at $9.28 sits below the 60-day and 200-day moving averages and above the 5-day, 10-day and 20-day.
Momentum readings: RSI stands at 52.221, MACD stands at -0.327 (Sell), Stochastic %K stands at 57.469, Stochastic %D stands at 53.794 and CCI stands at 178.955 (Sell).
BNTC trades below the 60-day SMA (10.59) and below the 200-day SMA (11.49). Immediate resistance sits at Classic R1 9.45, then R2 10.17. Support sits at Classic S1 7.95, then S2 7.16.
Benitec Biopharma Inc (BNTC) Support & Resistance Level
Benitec Biopharma Inc (BNTC) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 52.221 |
| STOCHk_14_3_3 | 57.469 |
| STOCHd_14_3_3 | 53.794 |
| CCI_20 | 178.955 |
| AO_5_34 | -0.434 |
| MOM_10 | 0.780 |
| MACD_12_26_9 | -0.327 |
Benitec Biopharma Inc (BNTC) Relative Strength Index (RSI_14) is 52.221, creating a Neutral signal.
Benitec Biopharma Inc (BNTC) Stochastic %K is 57.469, creating a Neutral signal.
Benitec Biopharma Inc (BNTC) Stochastic %D is 53.794, creating a Neutral signal.
Benitec Biopharma Inc (BNTC) CCI_20 is 178.955, creating a Sell signal.
Benitec Biopharma Inc (BNTC) Awesome Oscillator (AO) is -0.434, creating a Sell signal.
Benitec Biopharma Inc (BNTC) Momentum (MOM) is 0.780, creating a Buy signal.
Benitec Biopharma Inc (BNTC) Moving Average Convergence Divergence (MACD) is -0.327, creating a Sell signal.
Benitec Biopharma Inc (BNTC) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 8.748 | Buy |
| MA_10 | 8.728 | Buy |
| MA_20 | 8.668 | Buy |
| MA_60 | 10.591 | Sell |
| MA_200 | 11.495 | Sell |
| MA_250 | 11.722 | Sell |
Benitec Biopharma Inc (BNTC) 5-Day simple moving average is 8.748, while Benitec Biopharma Inc (BNTC) share price is $, making it a Buy.
Benitec Biopharma Inc (BNTC) 10-Day simple moving average is 8.728, while Benitec Biopharma Inc (BNTC) share price is $, making it a Buy.
Benitec Biopharma Inc (BNTC) 20-Day simple moving average is 8.668, while Benitec Biopharma Inc (BNTC) share price is $, making it a Buy.
Benitec Biopharma Inc (BNTC) 60-Day simple moving average is 10.591, while Benitec Biopharma Inc (BNTC) share price is $, making it a Sell.
Benitec Biopharma Inc (BNTC) 200-Day simple moving average is 11.495, while Benitec Biopharma Inc (BNTC) share price is $, making it a Sell.
Benitec Biopharma Inc (BNTC) 250-Day simple moving average is 11.722, while Benitec Biopharma Inc (BNTC) share price is $, making it a Sell.
Related articles
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
- AppLovin Q3 2026 Deep Dive: Beaten-Down S&P Dog Meets Axon Next-Gen Beat-and-Raise—and a $3.2B BuybaAppLovin Q3 2026: $2.185B rev (+55%), EPS $4.30 vs ~$4.03–4.04 Street, Adj EBITDA $1.842B (84%). Beat own guide $100M; Q4 $2.365–2.395B; auth +$3.2B; AH +22–24%.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.